Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
André Wolterbeek has a PhD in Toxicology with over more than 25 years CRO experience as scientist, study director and project leader in performing and monitoring of preclinical projects for the pharmaceutical, chemical and food industry.
He acquired much experience in the conduct and evaluation of preclinical IND-enabling studies for various therapeutic areas and was heavily involved in development of new methodologies.
He has thorough understanding of OECD, ICH and FDA guidelines and was involved in drafting new and/or updated guidelines. He is currently senior consultant non-clinical development and is leading the non-clinical department.
No articles found for this topic.
